x
SIGN UP
About Us
Back
Overview
Leadership Team
Board of Directors
Scientific Advisory Board
Partners
Careers
Science & Technology
Back
Protein Misfolding
SEE-Tx™ Platform
STARs
Publications
Posters
Pipeline
Back
Investors & Media
Back
Overview
News and Events
Stock Information
SEC Filings
Corporate Governance
Investor Resources
Analyst Coverage
Contact Us
Back
Perspectives
SearchIcon
Newsroom
Search
Events
December 5, 2023
FORCE Family Office/ Zacks Research Webinar
September 28, 2023
Cantor Global Healthcare Conference
September 13, 2023
FORCE Family Office Webinar
June 7, 2023
Jefferies 2023 Healthcare Conference
May 23, 2023
FORCE Family Office Webinar
March 29, 2023
Fireside Chat On Computational Biology in Drug Discovery with Key Opinion Leaders
March 14, 2023
Oppenheimer 33rd Annual Healthcare Conference
January 18, 2023
Sidoti Small-Cap Virtual Investor Conference
September 12 2022
H.C. Wainwright 24th Annual Global Investment Conference
June 10 2022
Jefferies Healthcare Conference
May 24 2022
H.C. Wainwright Global Investment Conference
April 28 2022
B. Riley Securities 2022 Virtual Neuro & Ophthalmology Conference
March 29-30 2022
Cantor Rare Orphan Disease Summit
March 27- April 1 2022
2022 Glycolipid and Sphingolipid Biology GRC
March 17 - 2022
Oppenheimer 32nd Annual Healthcare Conference
March 15 – 20, 2022
AD/PD™ 2022 International Conference on Alzheimer’s and Parkinson’s Diseases and related neurological disorders
March 15 - 18, 2022
Krabbe Translational Research Network Meeting
2022 GLYCOLIPID AND SPHINGOLIPID BIOLOGY GRC
Targeting glucocerebrosidase with structurally targeted allosteric regulators corrects abnormal phenotypes in models of Parkinson’s disease
February 7 – 11
18TH ANNUAL WORLDSYMPOSIUM ON LYSOSOMAL DISEASE RESEARCH
Friday, February 4th
GAIN THERAPEUTICS R&D DAY
November 10th - 2021
The Michael J. Fox Foundation’s Parkinson's Disease Therapeutics Webinars
November 11th - 2021
The Society of Neuroscience Annual Meeting
